查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
美國的婦產科設備市場 - 規模，趨勢(2023年～2029年):MedSuite
市場調查報告書
商品編碼
1304146

美國的婦產科設備市場 - 規模，趨勢(2023年～2029年):MedSuite

Gynecological Devices Market Analysis, Size, Trends | United States | 2023-2029 | MedSuite
出版日期: | 出版商: iData Research Inc. | 英文 332 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

到 2022 年，在每年約 300 萬例婦科手術的推動下，美國婦科設備市場將達到約 13 億美元。

本報告提供美國的婦產科設備市場相關調查，提供市場概要，以及各市場區隔趨勢，及加入此市場的主要企業的簡介等。

目錄

摘要整理

調查手法

COVID-19對美國的婦產科設備市場帶來的影響

疾病概要

  • 基本的解剖學
  • 病的治療和診斷
  • 患者的人口統計

產品的評估

  • 簡介
  • 產品系列
  • 法規上的問題和回收
  • 臨床試驗

美國的婦產科設備市場概要

  • 簡介
  • 市場概要與傾向分析
  • 促進因素與阻礙因素
    • 市場促進因素
    • 市場阻礙因素
  • 競爭市場佔有率分析
  • 合併和收購
  • 企業簡介
    • Boston Scientific
    • Coloplast
    • Cooper Surgical
    • Hologic
    • Laborie Medical
    • Medtronic
    • Merit Medical Systems
    • Minerva Surgical
    • Olympus
    • Richard Wolf
  • SWOT分析

手藝數量

  • 簡介
    • 卵巢癌症的發生率
    • 骨盆螢幕
  • 手藝數量概要

輔助生殖技術醫療設備市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

全球子宮內膜切除市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

子宮栓塞術設備市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

婦產科內視鏡市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

婦產科切除電極市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

婦科粉碎機市場

  • 簡介
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

骨盆底部電療設備市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

輸液治療設備市場T

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

骨盆器官脫垂修復設備市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

HSG導管市場

  • 簡介
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

附錄:子宮機械手市場

  • 簡介
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭市場佔有率分析

簡稱

Product Code: iDATA_USGYN23

In 2022, the gynecological devices market in the United States reached a value of approximately $1.3 billion, driven by nearly 3 million gynecological procedures performed annually. Our extensive research in the medical device market encompassed over 70 gynecological device companies across the United States. Through our comprehensive methodology, we analyzed market sizes, unit sales, company market shares, and developed accurate forecasts.

The complete report suite on the U.S. market for gynecological devices covers a wide range of products, including assisted reproduction technology devices, global endometrial ablation, uterine fibroid embolization devices, gynecological endoscopes, gynecological resection electrodes, morcellators, pelvic floor electrical stimulation devices, fluid management devices, pelvic organ prolapse repair devices, and hysterosalpingography (HSG) catheters.

DATA TYPES INCLUDED:

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Gynecological Procedure Volumes
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Gynecological Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

U.S. GYNECOLOGICAL DEVICES MARKET INSIGHTS

As companies vie for market share, pricing strategies in the gynecological devices industry become crucial. This has led to a downward trend in average selling prices (ASPs) across market segments. Lower prices may entice purchasers to explore alternative solutions, prompting providers of alternative gynecological devices to further reduce their prices in a cross-category price competition. The formation of purchasing groups by clinics has bolstered buyers' leverage, compelling sellers to offer competitive prices to secure broader market access. The competitive landscape puts pressure on sellers to ensure their pricing aligns with buyer expectations and demands.

One significant trend in the U.S. market for gynecological devices is the avoidance, when possible, of hysterectomies as a treatment option. Fibroids and endometriosis affect a significant proportion of women in the United States, with 20-25% of reproductive-age women and 11% of women between 15 and 44 being affected, according to the U.S. National Institutes of Health (NIH). To address these conditions, physicians are increasingly turning to minimally invasive treatments such as hysteroscopic surgeries, uterine artery embolization, and endometrial ablation, when the condition permits. These alternative procedures offer less invasiveness, shorter recovery periods, and have become preferred options for patients seeking to avoid the need for hysterectomy.

U.S. GYNECOLOGICAL DEVICES MARKET SHARE INSIGHTS

Hologic, Medtronic, Cooper Surgical, and Minerva Surgical emerged as the dominant players in the U.S. gynecological device market, collectively capturing more than 50% of the total market share.

Hologic dominated the U.S. gynecological device market with its strong presence in various segments, including global endometrial ablation, hysteroscopic morcellators, endoscopes, and fluid management devices.

Medtronic secured the second position, competing in the morcellator and fluid management device markets. Their TruClear™ Hysteroscopic morcellator contributed significantly to their market share in the morcellator device segment.

Minerva Surgical held the fourth position, participating in the global endometrial ablation, gynecological endoscope, morcellator, and fluid management markets. Their acquisition of the intrauterine portfolio from Boston Scientific in 2020 further strengthened their position.

Cooper Surgical emerged as the leading competitor in the assisted reproduction technology device, gynecological endoscope, and HSG catheter segments, contributing to their third-leading market share in the U.S. gynecological device market.

SEGMENTS COVERED:

  • Assisted reproduction technology devices
  • Global endometrial ablation
  • Uterine fibroid embolization devices
  • Gynecological endoscopes
  • Gynecological resection electrodes
  • Morcellator devices
  • Pelvic floor electrical stimulation devices
  • Fluid management devices
  • Pelvic organ prolapse repair devices
  • Hysterosalpingography (HSG) catheters

TABLE OF CONTENT

  • Table of Contents
  • List of Figures
  • List of Charts

Executive summary

  • U.S. Gynecological Device Market Overview
  • Competitive Analysis
  • Market Trends
  • Market Developments
  • Procedure Numbers
  • Procedure Codes Investigated
  • Markets Included
  • Key Report Updates
  • Version History

Research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

Impact of covid-19 on the U.S. Gynecological device Market

  • 2.1. Introduction
  • 2.2. Analysis By Market Segment
    • 2.2.1. Best Case Scenario
    • 2.2.2. Base Case Scenario
    • 2.2.3. Worst Case Scenario

Disease Overview

  • 3.1. Basic Anatomy
  • 3.2. Disease Treatment and Diagnostic
    • 3.2.1. Introduction
    • 3.2.2. General Diagnostics
    • 3.2.3. Assisted Reproduction Technologies (ART)
      • 3.2.3.1. ART Costs
    • 3.2.4. Abnormal Uterine Bleeding
    • 3.2.5. Gynecologic Cancer and Tumors in Reproductive System
    • 3.2.6. Female Sterilization
    • 3.2.7. Urinary Incontinence
    • 3.2.8. Pelvic Organ Prolapse
  • 3.3. Patient Demographics
    • 3.3.1. Assisted Reproduction Technologies (ART)
    • 3.3.2. Abnormal Uterine Bleeding
    • 3.3.3. Gynecologic Cancer and Tumors in Reproductive System
    • 3.3.4. Pelvic Organ Prolapse
    • 3.3.5. Endometriosis
    • 3.3.6. Polycystic ovary syndrome
    • 3.3.7. Female Sterilization

Product Assessment

  • 4.1. Introduction
  • 4.2. Product Portfolios
    • 4.2.1. Assisted Reproduction Technology Device
    • 4.2.2. Global Endometrial Ablation Market
    • 4.2.3. Uterine Fibroid Embolization Device
    • 4.2.4. Gynecological Endoscopes
    • 4.2.5. Gynecological Resection Electrode
    • 4.2.6. Gynecological Morcellators
    • 4.2.7. Pelvic Floor Electrical Stimulation Device
    • 4.2.8. Fluid Management Device
    • 4.2.9. Pelvic Organ Prolapse Repair Device
    • 4.2.10. HSG Catheter
    • 4.2.11. Uterine Manipulators
  • 4.3. Regulatory Issues and Recalls
    • 4.3.1. Assisted Reproduction Technology Device Market
    • 4.3.2. Gynecological Endoscope Market
    • 4.3.3. Gynecological Resection Electrode Market
    • 4.3.4. Morcellator Market
    • 4.3.5. Fluid Management Device Market
    • 4.3.6. Pelvic Organ Prolapse Repair Device Market
    • 4.3.7. HSG Catheter Market
    • 4.3.8. Uterine Manipulator Market
  • 4.4. Clinical Trials
    • 4.4.1. Assisted Reproduction Technology Device
    • 4.4.2. Global Endometrial Ablation
    • 4.4.3. Uterine Fibroid Embolization Device
    • 4.4.4. Gynecological Endoscopes
    • 4.4.5. Gynecological Morcellators
    • 4.4.6. Pelvic Floor Electrical Stimulation Device
    • 4.4.7. Pelvic Organ Prolapse Repair Device
    • 4.4.8. Uterine Manipulators

U.S. Gynecological Device Market Overview

  • 5.1. Introduction
  • 5.2. Market Overview and Trend Analysis
  • 5.3. Drivers and Limiters
    • 5.3.1. Market Drivers
    • 5.3.2. Market Limiters
  • 5.4. Competitive Market Share Analysis
  • 5.5. Mergers and Acquisitions
  • 5.6. Company Profiles
    • 5.6.1. Boston Scientific
    • 5.6.2. Coloplast
    • 5.6.3. Cooper Surgical
    • 5.6.4. Hologic
    • 5.6.5. Laborie Medical
    • 5.6.6. Medtronic
    • 5.6.7. Merit Medical Systems
    • 5.6.8. Minerva Surgical
    • 5.6.9. Olympus
    • 5.6.10. Richard Wolf
  • 5.7. SWOT Analysis
    • 5.7.1. Boston Scientific
    • 5.7.2. Coloplast
    • 5.7.3. Cooper Surgical
    • 5.7.4. Hologic
    • 5.7.5. Laborie Medical
    • 5.7.6. Medtronic
    • 5.7.7. Merit Medical Systems
    • 5.7.8. Minerva Surgical
    • 5.7.9. Olympus
    • 5.7.10. Richard Wolf

Procedure Numbers

  • 6.1. Introduction
    • 6.1.1. Ovarian Cancer Incidence
    • 6.1.2. Pelvic Screens
  • 6.2. Procedures Number Overview
    • 6.2.1. Fallopian Tube Procedures
    • 6.2.2. Assisted Reproduction Technology Procedures by Type
    • 6.2.3. Cervical Repair and Biopsy Procedures
    • 6.2.4. Global Endometrial Ablation Procedures
      • 6.2.4.1. Thermal Ablation Procedures
      • 6.2.4.2. Hydrothermal Ablation Procedures
      • 6.2.4.3. Radiofrequency Ablation Procedures
      • 6.2.4.4. Cryoablation Procedures
    • 6.2.5. Uterine Fibroid Embolization Procedures by Type
    • 6.2.6. Gynecological Endoscope Procedures
    • 6.2.7. Morcellation Procedures
    • 6.2.8. Vaginal Procedures
    • 6.2.9. Pelvic Organ Prolapse Procedures by Type
    • 6.2.10. HSG Catheter Procedures by Type
    • 6.2.11. Myomectomy Procedures
    • 6.2.12. Hysterectomy Procedures
      • 6.2.12.1. Hysterectomy Procedures by Type
      • 6.2.12.1. Hysterectomy Procedures by Approach

Assisted Reproduction Technology Device Market

  • 7.1. Introduction
    • 7.1.1. Media
    • 7.1.2. Vitrification
  • 7.2. Market Overview
  • 7.3. Market Analysis and Forecast
    • 7.3.1. Oocyte Retrieval Needle Market
    • 7.3.2. Micropipette Market
      • 7.3.2.1. Flexible Pipette Market
      • 7.3.2.2. ICSI Pipette Market
    • 7.3.3. Embryo Transfer Catheter Market
    • 7.3.4. Reproduction Media Market
      • 7.3.4.1. Culture Media Market
      • 7.3.4.2. Sperm Preparation Media Market
      • 7.3.4.3. Manipulation Media Market
      • 7.3.4.4. Freeze/Thaw Media Market
  • 7.4. Drivers and Limiters
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. Competitive Market Share Analysis

Global Endometrial Ablation Market

  • 8.1. Introduction
    • 8.1.1. Hydrothermal Ablation
    • 8.1.2. Radiofrequency Ablation
    • 8.1.3. Cryoablation
    • 8.1.4. Roller-Ball Ablation
  • 8.2. Market Overview
  • 8.3. Market Analysis and Forecast
    • 8.3.1. Total Global Endometrial Ablation Market
    • 8.3.2. Thermal Ablation Device Market
    • 8.3.3. Hydrothermal Ablation Device Market
    • 8.3.4. Radiofrequency Ablation Device Market
    • 8.3.5. Cryoablation Device Market
  • 8.4. Drivers and Limiters
    • 8.4.1. Market Drivers
    • 8.4.2. Market Limiters
  • 8.5. Competitive Market Share Analysis

Uterine Fibroid Embolization Device Market

  • 9.1. Introduction
    • 9.1.1. Microspheres
    • 9.1.2. Polyvinyl Alcohol Particles
    • 9.1.3. Drug-Eluting Particles
  • 9.2. Market Overview
  • 9.3. Market Analysis and Forecast
    • 9.3.1. Microsphere Market
    • 9.3.2. PVA Particle Market
  • 9.4. Drivers and Limiters
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. Competitive Market Share Analysis

Gynecological Endoscope Market

  • 10.1. Introduction
    • 10.1.1. Hysteroscopes
    • 10.1.2. Colposcopes
    • 10.1.3. Resectoscopes
  • 10.2. Market Overview
  • 10.3. Market Analysis and Forecast
    • 10.3.1. Hysteroscope Market
      • 10.3.1.1. Reusable Hysteroscope Market
      • 10.3.1.2. Reusable Rigid Hysteroscope Market
      • 10.3.1.3. Reusable Flexible Hysteroscope Market
      • 10.3.1.3.1. Video Flexible Hysteroscope Market
      • 10.3.1.3.2. Fiber Flexible Hysteroscope Market
      • 10.3.1.4. Disposable Hysteroscope Market
    • 10.3.2. Colposcope Market
      • 10.3.2.1. Video Colposcope Market
      • 10.3.2.2. Non-Video Colposcope Market
    • 10.3.3. Resectoscope Market
  • 10.4. Drivers and Limiters
    • 10.4.1. Market Drivers
    • 10.4.2. Market Limiters
  • 10.5. Competitive Market Share Analysis

Gynecological Resection Electrode Market

  • 11.1. Introduction
  • 11.2. Market Overview
  • 11.3. Market Analysis and Forecast
    • 11.3.1. Monopolar Loop Electrode Market
    • 11.3.2. Bipolar Loop Electrode Market
  • 11.4. Drivers and Limiters
    • 11.4.1. Market Drivers
    • 11.4.2. Market Limiters
  • 11.5. Competitive Market Share Analysis

Morcellator Market

  • 12.1. Introduction
  • 12.2. Market Analysis and Forecast
    • 12.2.1. Laparoscopic Morcellator Market
    • 12.2.2. Hysteroscopic Morcellator Market
  • 12.3. Drivers and Limiters
    • 12.3.1. Market Drivers
    • 12.3.2. Market Limiters
  • 12.4. Competitive Market Share Analysis

Pelvic Floor Electrical Stimulation Device Market

  • 13.1. Introduction
  • 13.2. Market Overview
  • 13.3. Market Analysis and Forecast
    • 13.3.1. Home-Based PFES Device Market
    • 13.3.2. Office-Based PFES Device Market
  • 13.4. Drivers and Limiters
    • 13.4.1. Market Drivers
    • 13.4.2. Market Limiters
  • 13.5. Competitive Market Share Analysis

Fluid Management Device MarkeT

  • 14.1. Introduction
  • 14.2. Market Overview
  • 14.3. Market Analysis and Forecast
    • 14.3.1. Fluid Management Equipment Market
    • 14.3.2. Fluid Management Tubing Market
  • 14.4. Drivers and Limiters
    • 14.4.1. Market Drivers
    • 14.4.2. Market Limiters
  • 14.5. Competitive Market Share Analysis

Pelvic Organ Prolapse Repair Device Market

  • 15.1. Introduction
  • 15.2. Market Overview
  • 15.3. Market Analysis and Forecast
    • 15.3.1. Transvaginal Mesh Market
    • 15.3.2. Sacrocolpopexy Mesh Market
  • 15.4. Drivers and Limiters
    • 15.4.1. Market Drivers
    • 15.4.2. Market Limiters
  • 15.5. Competitive Market Share Analysis

HSG Catheter Market

  • 16.1. Introduction
  • 16.2. Market Analysis and Forecast
  • 16.3. Drivers and Limiters
    • 16.3.1. Market Drivers
    • 16.3.2. Market Limiters
  • 16.4. Competitive Market Share Analysis

Appendix: Uterine Manipulator market

  • 17.1. Introduction
  • 17.2. Market Analysis and Forecast
  • 17.3. Drivers and Limiters
    • 17.3.1. Market Drivers
    • 17.3.2. Market Limiters
  • 17.4. Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Gynecological Device Market Value, U.S., 2019 - 2029
  • Chart 1-2: Gynecological Device Market Overview, U.S., 2022 & 2029
  • Chart 2-1: Multi-Scenario Gynecological Device Market Forecast, U.S., 2019 - 2029 (US$M)
  • Chart 5-1: Gynecological Device Market by Segment, U.S., 2019 - 2029
  • Chart 5-2: Leading Competitors, Gynecological Device Market, U.S., 2022
  • Chart 6-1: Gynecological Procedures by Type, U.S., 2019 - 2029
  • Chart 7-1: Assisted Reproduction Technology Device Market by Segment, U.S., 2019 - 2029
  • Chart 7-2: Leading Competitors, Assisted Reproduction Technology Device Market, U.S., 2022
  • Chart 8-1: Global Endometrial Ablation Market by Segment, U.S., 2019 - 2029
  • Chart 8-2: Leading Competitors, Global Endometrial Ablation Market, U.S., 2022
  • Chart 9-1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2019 - 2029
  • Chart 9-2: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2022
  • Chart 10-1: Gynecological Endoscope Market by Segment, U.S., 2019 - 2029
  • Chart 10-2: Leading Competitors, Hysteroscope Market, U.S., 2022
  • Chart 11-1: Gynecological Electrosurgery Market, U.S., 2019 - 2029
  • Chart 11-2: Leading Competitors, Gynecological Resection Device Market, U.S., 2022
  • Chart 12-1: Gynecological Morcellator Market, U.S., 2019 - 2029
  • Chart 12-2: Leading Competitors, Morcellator Market, U.S., 2022
  • Chart 13-1: Pelvic Floor Electrical Stimulation Device Market by Segment, U.S., 2019 - 2029
  • Chart 13-2: Leading Competitors, Pelvic Floor Electrical Stimulation Device Market, U.S., 2022
  • Chart 14-1: Fluid Management Device Market by Segment, U.S., 2019 - 2029
  • Chart 14-2: Leading Competitors, Fluid Management Device Market, U.S., 2022
  • Chart 15-1: Pelvic Organ Prolapse Repair Device Market by Segment, U.S., 2019 - 2029
  • Chart 15-2: Leading Competitors, Pelvic Organ Prolapse Repair Device Market, U.S., 2022
  • Chart 16-1: HSG Catheter Market by segment, U.S., 2019 - 2029
  • Chart 16-2: Leading Competitors, HSG Catheter Market, U.S., 2022
  • Chart 17-1: Uterine Manipulator Market, U.S., 2019 - 2029
  • Chart 17-2: Leading Competitors, Uterine Manipulator Market, U.S., 2022

LIST OF FIGURES

  • Figure 1-1: Gynecological Device Market Share Ranking by Segment, U.S., 2022 (1 of 2)
  • Figure 1-2: Gynecological Device Market Share Ranking by Segment, U.S., 2022 (2 of 2)
  • Figure 1-3: Companies Researched in This Report (1 of 2)
  • Figure 1-4: Companies Researched in This Report (2 of 2)
  • Figure 1-5: Factors Impacting the Gynecological Device Market by Segment, U.S. (1 of 2)
  • Figure 1-6: Factors Impacting the Gynecological Device Market by Segment, U.S. (2 of 2)
  • Figure 1-7: Recent Events in the Gynecological Device Market, U.S., 2019 - 2023 (1 of 2)
  • Figure 1-8: Recent Events in the Gynecological Device Market, U.S., 2019 - 2023 (2 of 2)
  • Figure 1-9: Gynecological Device Procedures Covered (1 of 2)
  • Figure 1-10: Gynecological Device Procedures Covered (2 of 2)
  • Figure 1-11: Procedure Codes Investigated
  • Figure 1-12: Gynecological Device Markets Covered (1 of 2)
  • Figure 1-13: Gynecological Device Markets Covered (2 of 2)
  • Figure 1-14: Key Report Updates
  • Figure 1-15: Version History
  • Figure 2-1: Gynecological Market by Segment, Best Case Scenario, U.S., 2019 - 2029 (US$M) (1 of 2)
  • Figure 2-2: Gynecological Market by Segment, Best Case Scenario, U.S., 2019 - 2029 (US$M) (2 of 2)
  • Figure 2-3: Gynecological Market by Segment, Base Case Scenario, U.S., 2019 - 2029 (US$M) (1 of 2)
  • Figure 2-4: Gynecological Market by Segment, Base Case Scenario, U.S., 2019 - 2029 (US$M) (2 of 2)
  • Figure 2-5: Gynecological Market by Segment, Worst Case Scenario, U.S., 2019 - 2029 (US$M) (1 of 2)
  • Figure 2-6: Gynecological Market by Segment, Worst Case Scenario, U.S., 2019 - 2029 (US$M) (2 of 2)
  • Figure 3-1: Gynecological Disease Overview
  • Figure 3-2: ART Procedure Availability Overview
  • Figure 3-3: Female Sterilization Estimation
  • Figure 4-1: Assisted Reproduction Technology Device by Company (1 of 2)
  • Figure 4-2: Assisted Reproduction Technology Device by Company (2 of 2)
  • Figure 4-3: Global Endometrial Ablation Market by Company
  • Figure 4-4: Uterine Fibroid Embolization Device Market by Company
  • Figure 4-5: Gynecological Endoscope Market by Company (1 of 2)
  • Figure 4-6: Gynecological Endoscope Market by Company (2 of 2)
  • Figure 4-7: Gynecological Resection Electrode Market by Company
  • Figure 4-8: Morcellator Market by Company
  • Figure 4-9: Pelvic Floor Electrical Stimulation Device Market by Company
  • Figure 4-10: Fluid Management Device Market by Company
  • Figure 4-11: Pelvic Organ Prolapse Repair Device Market by Company
  • Figure 4-12: HSG Catheter Market by Company
  • Figure 4-13: Uterine Manipulator Market by Company
  • Figure 4-14: Class 2 Device Recall BIOPSY MEDIUM
  • Figure 4-15: Class 2 Device Recall LifeGlobal Fast Freeze Thawing Kit
  • Figure 4-16: Class 2 Device Recall Vitrification Freeze Kit
  • Figure 4-17: Class 2 Device Recall MediCult Vitrification Cooling Media
  • Figure 4-18: Class 3 Device Recall
  • Figure 4-19: Class 2 Device Recall Guardia Access Nano Embryo Transfer Catheter
  • Figure 4-20: Class 2 Device Recall Embryo Transfer Catheters/Sets
  • Figure 4-21: Class 2 Device Recall Advanced Endosee Cannula
  • Figure 4-22: Class 2 Device Recall HF Resection Electrodes
  • Figure 4-23: Class 2 Device Recall Covidien TruClear Hysteroscopic Tissue Removal System
  • Figure 4-24: Class 2 Device Recall PneumoLiner
  • Figure 4-25: Class 2 Device Recall HysteroLux" Fluid Management System
  • Figure 4-26: Class 2 Device Recall Aquilex Fluid Control System Component: Bag Deflector
  • Figure 4-27: Class 2 Device Recall Colpassist Vaginal Positioning Device
  • Figure 4-28: Class 2 Device Recall Upsylon YMesh Kit with Colpassist Vaginal Positioning Device
  • Figure 4-29: Class 2 Device Recall VERITAS Collagen Matrix
  • Figure 4-30: Class 2 Device Recall Uphold Vaginal Support System
  • Figure 4-31: Class 2 Device Recall Posterior LITE w/ Capio SLIM
  • Figure 4-32: Class 2 Device Recall PFR Kit Pinnacle
  • Figure 4-33: Class 2 Device Recall McKesson
  • Figure 4-34: Class 2 Device Recall Cannula, Manipulator/Injector, Uterine
  • Figure 4-35: Class 2 Device Recall Advincula Delineator
  • Figure 4-36: The Impact of Past Coronavirus Disease 19 (COVID-19) Infection on the Live Birth Rates of Frozen Embryo Transfer Cycles
  • Figure 4-37: Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF) (ACIDOFIV)
  • Figure 4-38: Assessment of Embryo Viability and Re-expansion After Thawing in Blastocyst Stage Embryos
  • Figure 4-39: Heated and Non Heated Ovarian Aspiration Needle Protocol
  • Figure 4-40: Fresh Vs Frozen Surgical Sperm in IVF
  • Figure 4-41: Comparing Two Types of Needle for Oocytes Retrieval (NEEDLE)
  • Figure 4-42: Comparison of Two Embryo Transfer Catheters in Patients Undergoing in Vitro Fertilization and Embryo Transfer
  • Figure 4-43: Male Fertility and Sperm Cryopreservation
  • Figure 4-44: Embryo Transfer with Self-spent Culture Medium
  • Figure 4-45: EmbryoGlue as an Embryo Transfer Medium
  • Figure 4-46: Influence of Post-thaw Embryo Culture Interval on Assisted Reproduction Success Rates
  • Figure 4-47: NovaSure Study: Endometrial Ablation in Women with Heavy Menstrual Bleeding (RAMBOS)
  • Figure 4-48: Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System
  • Figure 4-49: Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids
  • Figure 4-50: UA Versus UAE in Treatment of Fibroids
  • Figure 4-51: Satisfaction of Patients with Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial (SPARQLE)
  • Figure 4-52: A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery
  • Figure 4-53: Safety and Efficacy of Using PK Morcellator with Pneumoliner Containment Hysterectomy
  • Figure 4-54: Treatment of Missed Miscarriage with TRUCLEAR Tissue Removal System, a Feasibility Study
  • Figure 4-55: The Hysteroscopic Morcellator (HM)
  • Figure 4-56: Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (RESMO)
  • Figure 4-57: A Randomized Controlled Trial of Electrical Stimulation to Treat Pelvic Floor Disorder
  • Figure 4-58: A Study of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence
  • Figure 4-59: Evaluation of the Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser Treatment on Urinary Stress Incontinence
  • Figure 4-60: the Effect of a New Type of Pelvic Floor Rehabilitation Device PHENIX U4+ on the Treatment of Urinary Incontinence
  • Figure 4-61: Electrical Stimulation in Women with Pelvic Organ Prolapse
  • Figure 4-62: Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Stress Urinary Incontinence Symptoms
  • Figure 4-63: Effect of External Electrical Stimulation and Pelvic Floor Muscle Training
  • Figure 4-64: Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh (SAME)
  • Figure 4-65: Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair (CASPO)
  • Figure 4-66: SCP vs HUSLS for Pelvic Organ Prolapse Repair
  • Figure 4-67: Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)
  • Figure 4-68: Restorelle® Mesh Versus Native Tissue Repair for Prolapse
  • Figure 4-69: Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse
  • Figure 4-70: Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial (ACRAS)
  • Figure 4-71: Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial (MANEC)
  • Figure 4-72: Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study (proMUCEI)
  • Figure 4-73: Pilot Trial of the Robotic Uterine Manipulator
  • Figure 4-74: Trial of YUMI Uterine Manipulator
  • Figure 5-1: Gynecological Market by Segment, U.S., 2019 - 2029 (US$M) (1 of 2)
  • Figure 5-2: Gynecological Market by Segment, U.S., 2019 - 2029 (US$M) (2 of 2)
  • Figure 5-3: Leading Competitors, Gynecological Device Market, U.S., 2022 (1 of 2)
  • Figure 5-4: Leading Competitors, Gynecological Device Market, U.S., 2022 (2 of 2)
  • Figure 5-5: SWOT Analysis, Boston Scientific
  • Figure 5-6: SWOT Analysis, Coloplast
  • Figure 5-7: SWOT Analysis, Cooper Surgical
  • Figure 5-8: SWOT Analysis, Hologic
  • Figure 5-9: SWOT Analysis, Laborie Medical
  • Figure 5-10: SWOT Analysis, Medtronic
  • Figure 5-11: SWOT Analysis, Merit Medical Systems
  • Figure 5-12: SWOT Analysis, Minerva Surgical
  • Figure 5-13: SWOT Analysis, Olympus
  • Figure 5-14: SWOT Analysis, Richard Wolf
  • Figure 6-1: Ovarian Cancer Incidence, U.S., 2019 - 2029
  • Figure 6-2: Pelvic Screens, U.S., 2019 - 2029
  • Figure 6-3: Procedure Codes Investigated
  • Figure 6-4: Gynecological Procedures by Type, U.S., 2019 - 2029 (1 of 2)
  • Figure 6-5: Gynecological Procedures by Type, U.S., 2019 - 2029 (2 of 2)
  • Figure 6-6: Fallopian Tube Procedures, U.S., 2019 - 2029
  • Figure 6-7: Assisted Reproduction Technology Procedures by Type, U.S., 2019 - 2029
  • Figure 6-8: Cervical Repair and Biopsy Procedures, U.S., 2019 - 2029
  • Figure 6-9: Global Endometrial Ablation Procedures by Modality, U.S., 2019 - 2029
  • Figure 6-10: Uterine Fibroid Embolization Procedures by Type, U.S., 2019 - 2029
  • Figure 6-11: Gynecological Endoscopy Procedures, U.S., 2019 - 2029
  • Figure 6-12: Morcellation Procedures by Type, U.S., 2019 - 2029
  • Figure 6-13: Vaginal Procedures, U.S., 2019 - 2029
  • Figure 6-14: Pelvic Organ Prolapse Procedures by Type, U.S., 2019 - 2029
  • Figure 6-15: HSG Catheter Procedures by Type, U.S., 2019 - 2029
  • Figure 6-16: Myomectomy Procedures, U.S., 2019 - 2029
  • Figure 6-17: Hysterectomy Procedures by Type, U.S., 2019 - 2029
  • Figure 6-18: Hysterectomy Procedures by Approach, U.S., 2019 - 2029
  • Figure 7-1: Assisted Reproduction Technology Device Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 7-2: Oocyte Retrieval Needle Market, U.S., 2019 - 2029
  • Figure 7-3: Micropipette Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 7-4: Micropipette Market, U.S., 2019 - 2029
  • Figure 7-5: Flexible Pipette Market, U.S., 2019 - 2029
  • Figure 7-6: ICSI Pipette Market, U.S., 2019 - 2029
  • Figure 7-7: Embryo Transfer Catheter Market, U.S., 2019 - 2029
  • Figure 7-8: Reproduction Media Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 7-9: Reproduction Media Market, U.S., 2019 - 2029
  • Figure 7-10: Culture Media Market, U.S., 2019 - 2029
  • Figure 7-11: Sperm Preparation Media Market, U.S., 2019 - 2029
  • Figure 7-12: Manipulation Media Market, U.S., 2019 - 2029
  • Figure 7-13: Freeze/Thaw Media Market, U.S., 2019 - 2029
  • Figure 7-14: Leading Competitors, Assisted Reproduction Technology Device Market, U.S., 2022
  • Figure 8-1: Global Endometrial Ablation Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 8-2: Total Global Endometrial Ablation Market, U.S., 2019 - 2029
  • Figure 8-3: Thermal Ablation Device Market, U.S., 2019 - 2029
  • Figure 8-4: Hydrothermal Ablation Device Market, U.S., 2019 - 2029
  • Figure 8-5: Radiofrequency Ablation Device Market, U.S., 2019 - 2029
  • Figure 8-6: Cryoablation Device Market, U.S., 2019 - 2029
  • Figure 8-7: Leading Competitors, Global Endometrial Ablation Market, U.S., 2022
  • Figure 9-1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 9-2: Microsphere Market, U.S., 2019 - 2029
  • Figure 9-3: PVA Particle Market, U.S., 2019 - 2029
  • Figure 9-4: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2022
  • Figure 10-1: Gynecological Endoscope Market, U.S., 2019 - 2029 (US$M)
  • Figure 10-2: Total Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-3: Total Reusable Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-4: Reusable Rigid Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-5: Reusable Flexible Hysteroscope Market by Segment, U.S., 2019 - 2029
  • Figure 10-6: Total Reusable Flexible Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-7: Video Flexible Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-8: Fiber Flexible Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-9: Disposable Hysteroscope Market, U.S., 2019 - 2029
  • Figure 10-10: Total Colposcope Market, U.S., 2019 - 2029
  • Figure 10-11: Colposcope Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 10-12: Video Colposcope Market, U.S., 2019 - 2029
  • Figure 10-13: Non-Video Colposcope Market, U.S., 2019 - 2029
  • Figure 10-14: Resectoscope Market, U.S., 2019 - 2029
  • Figure 10-15: Leading Competitors, Gynecological Endoscope Market, U.S., 2022
  • Figure 11-1: Gynecological Electrosurgery Device Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 11-2: Monopolar Loop Electrode Market, U.S., 2019 - 2029
  • Figure 11-3: Bipolar Loop Electrode Market, U.S., 2019 - 2029
  • Figure 11-4: Leading Competitors, Gynecological Resection Device Market, U.S., 2022
  • Figure 12-1: Morcellator Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 12-2: Laparoscopic Morcellator Market, U.S., 2019 - 2029
  • Figure 12-3: Hysteroscopic Morcellator Market, U.S., 2019 - 2029
  • Figure 12-4: Leading Competitors, Morcellator Market, U.S., 2022
  • Figure 13-1: Pelvic Floor Electrical Stimulation Device Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 13-2: Home-Based PFES Device Market, U.S., 2019 - 2029
  • Figure 13-3: Office-Based PFES Device Market, U.S., 2019 - 2029
  • Figure 13-4: Leading Competitors, Pelvic Floor Electrical Stimulation Device Market, U.S., 2022
  • Figure 14-1: Fluid Management Device Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 14-2: Fluid Management Equipment Market, U.S., 2019 - 2029
  • Figure 14-3: Fluid Management Tubing Market, U.S., 2019 - 2029
  • Figure 14-4: Leading Competitors, Fluid Management Device Market, U.S., 2022
  • Figure 15-1: Pelvic Organ Prolapse Repair Device Market by Segment, U.S., 2019 - 2029 (US$M)
  • Figure 15-2: Sacrocolpopexy Mesh Market, U.S., 2019 - 2029
  • Figure 15-3: Leading Competitors, Pelvic Organ Prolapse Repair Device Market, U.S., 2022
  • Figure 16-1: HSG Catheter Market, U.S., 2019 - 2029
  • Figure 16-2: Leading Competitors, HSG Catheter Market, U.S., 2022
  • Figure 17-1: Uterine Manipulator Market, U.S., 2019 - 2029
  • Figure 17-2: Leading Competitors, Uterine Manipulator Market, U.S., 2022